Jaromir Sykora

Yes and PI3K Bind CD95 to Signal Invasion of Glioblastoma

Susanne Kleber, Ignacio Sancho-Martinez, Alexandra Beisel et al. · Cancer Cell · 2008 · 298 citations · Full text

Medicine, Cell Biology, Oncology +14

Preclinical Differentiation between Apparently Safe and Potentially Hepatotoxic Applications of TRAIL Either Alone or in Combination with Chemotherapeutic Drugs

Tom M. Ganten, Ronald Koschny, Jaromir Sykora et al. · Clinical Cancer Research · 2006 · 213 citations · Full text

Life Sciences, Pharmacology, Toxicology +17

Proteasome Inhibition Sensitizes Hepatocellular Carcinoma Cells, But Not Human Hepatocytes, to TRAIL *

Tom M. Ganten, Ronald Koschny, Tobias L. Haas et al. · Hepatology · 2005 · 171 citations · Full text

Life Sciences, Oncology, Pharmacology +14

Bortezomib Sensitizes Primary Human Astrocytoma Cells of WHO Grades I to IV for Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis

Ronald Koschny, Heidrun Holland, Jaromir Sykora et al. · Clinical Cancer Research · 2007 · 120 citations

Medicine, Oncology, Pharmacology +17

TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window

Ronald Koschny, Tom M. Ganten, Jaromir Sykora et al. · Hepatology · 2007 · 113 citations · Full text

Life Sciences, Oncology, Pharmacology +17